US Patent 7589186 Isolated hOAT polynucleotide

Patent 7589186 was granted and assigned to Gilead Sciences on September, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 17 Sep, 2023

"Add patent inventor(s)"

Golden AI

edited on 17 Sep, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Inventor Names

Tomas Cihlar0

Edits on 16 Sep, 2023

"Add patent abstract"

Golden AI

edited on 16 Sep, 2023

Edits made to:

Article (+557 characters)

Article

Patent abstract

This invention is concerned with human organic anion transporter (“hOAT”). Isolated nucleic acid encoding hOAT is provided, along with isolated hOAT polypeptide. hOAT nucleic acid and/or hOAT polypeptide are employed in transgenic animals, recombinant cells, replicable vectors and analytical procedures for identifying hOAT agonists or antagonists, assays for identifying hOAT alleles and/or isotypes, screening tests for nephrotoxic or neurologically active compounds, and determination of drug-drug interactions within the kidney or brain.

Edits on 22 May, 2023

"Remove website redirecting to Patent Public Search front page"

Golden AI

edited on 22 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=075891860

Edits on 18 May, 2023

"Remove leading 0 from patent number"

Golden AI